Hennrikus Deborah J, Lando Harry A, McCarty Maribet C, Klevan David, Holtan Neal, Huebsch Jacquelyn A, Jestus Sharon, Pentel Paul R, Pine Donald, Sullivan Susan, Swenson Karen, Vessey John
Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.
Prev Med. 2005 Mar;40(3):249-58. doi: 10.1016/j.ypmed.2004.05.030.
This study evaluated the effectiveness of three smoking cessation interventions for this population: (1) modified usual care (UC); (2) brief advice (A); and (3) brief advice plus more extended counseling during and after hospitalization (A + C).
Smokers (2,095) who were in-patients in four hospitals were randomly assigned to condition. Smoking status was ascertained via phone interview 7 days and 12 months post-discharge. At 12 months, reports of abstinence were validated by analysis of saliva cotinine. Intent to treat analyses were performed.
At 7-day follow-up, 24.2% of participants reported abstinence in the previous 7 days. There were no differences between conditions. At 12-month follow-up, self-reported abstinence was significantly higher in the A + C condition (UC (15.0%) vs. A (15.2%) vs. A + C (19.8%)). There was no significant difference among conditions in cotinine-validated abstinence, however (UC (8.8%) vs. A (10.0%) vs. A + C (9.9%)).
These interventions for hospital in-patients did not increase abstinence rates. Features of the study that might have contributed to this finding were the inclusiveness of the participation criteria, the fact that pharmacological aids were not provided, and a stage-matching approach that resulted in less intensive counseling for participants unwilling to set a quit date.
本研究评估了针对该人群的三种戒烟干预措施的效果：（1）改良常规护理（UC）；（2）简短建议（A）；（3）在住院期间及出院后提供简短建议并增加更深入的咨询（A + C）。
四家医院的2095名住院吸烟者被随机分配到相应组别。出院7天和12个月后通过电话访谈确定吸烟状况。在12个月时，通过唾液可替宁分析验证戒烟报告。进行意向性分析。
在7天随访时，24.2%的参与者报告在过去7天内戒烟。各组别之间无差异。在12个月随访时，自我报告的戒烟率在A + C组显著更高（UC组为15.0%，A组为15.2%，A + C组为19.8%）。然而，在可替宁验证的戒烟方面，各组别之间无显著差异（UC组为8.8%，A组为10.0%，A + C组为9.9%）。
这些针对住院患者的干预措施并未提高戒烟率。可能导致这一结果的研究特点包括参与标准的包容性、未提供药物辅助以及一种阶段匹配方法，该方法导致对不愿设定戒烟日期的参与者提供的咨询强度较低。
